Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001308275 | SCV001497717 | uncertain significance | Renal carnitine transport defect | 2021-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with aspartic acid at codon 484 of the SLC22A5 protein (p.Gly484Asp). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and aspartic acid. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with SLC22A5-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV002226536 | SCV002078360 | uncertain significance | Decreased circulating carnitine concentration | 2020-09-30 | no assertion criteria provided | clinical testing | |
Natera, |
RCV001308275 | SCV002107483 | uncertain significance | Renal carnitine transport defect | 2020-09-30 | no assertion criteria provided | clinical testing |